Agilon Health Inc. (NYSE: AGL) reported Q2 EPS of ($0.25), $0.14 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.47 billion.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.